Zepp Health (NYSE:ZEPP) PT Set at $14.65 by Fundamental Research

Zepp Health (NYSE:ZEPP) received a $14.65 price target from equities research analysts at Fundamental Research in a report issued on Tuesday,BayStreet.CA reports. The firm presently has a “buy” rating on the stock. Fundamental Research’s price target indicates a potential upside of 432.73% from the stock’s current price.

Zepp Health Stock Performance

Shares of ZEPP opened at $2.75 on Tuesday. The company has a current ratio of 1.21, a quick ratio of 0.87 and a debt-to-equity ratio of 0.13. The firm has a market cap of $41.39 million, a PE ratio of -1.10 and a beta of 0.68. The company’s 50 day simple moving average is $3.35 and its 200-day simple moving average is $2.99. Zepp Health has a 12-month low of $2.06 and a 12-month high of $8.40.

Hedge Funds Weigh In On Zepp Health

A hedge fund recently bought a new stake in Zepp Health stock. Virtu Financial LLC bought a new position in shares of Zepp Health Co. (NYSE:ZEPP) during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 13,056 shares of the company’s stock, valued at approximately $57,000. Virtu Financial LLC owned about 0.09% of Zepp Health at the end of the most recent quarter. 52.61% of the stock is currently owned by hedge funds and other institutional investors.

About Zepp Health

Zepp Health Corporation operates as a smart wearable and health technology company worldwide. The company operates in two segments: Self-Branded Products and Others, and Xiaomi Wearable Products. It empowers users to live lives by optimizing health, fitness, and wellness journeys through its consumer brands, Amazfit, Zepp Clarity, and Zepp Aura.